Healthcare / Medical DevicesUpdated 2026-05-10 22:07 UTC

CPH/AMBU.B stock hub

CPH/AMBU.B has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

CPH/AMBU.Bis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

16.5B

Copenhagen Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

CPH/AMBU.B

In the news

Latest news · CPH/AMBU.B

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E23.3

P25 14.6P50 19.5P75 24.2

Trailing P/E34.9

P25 11.8P50 20.8P75 32.9

ROE7.9

P25 -4.6P50 11.3P75 24.2

ROIC8.5

P25 -8.1P50 8.5P75 13.1

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All CPH/AMBU.B market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

246

Groups with data

Currency

DKK

Showing 246 of 246 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Denmark
Country code	DK
Employees	5,200
Employees Change	200%
Employees Change Percent	4
Enterprise value	DKK 16.4B
Exchange	Copenhagen Stock Exchange
Financial currency	DKK
First seen	2026-05-10
Industry	Medical Devices
Isin	DK0060946788
Last refreshed	2026-05-10
Market cap	DKK 16.5B
Price	DKK 62.4
Price currency	DKK
Rev Per Employee	1,173,846.15x
Sector	Healthcare
Sic	3841
Symbol	cph/AMBU.B
Website	https://www.ambu.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	2.88%
EV Earnings	34.39x
EV/EBIT	25.08x
EV/EBITDA	18.64x
EV/FCF	23.94x
EV/Sales	2.69x
FCF yield	4.14%
Forward P/E	23.3x
P/B ratio	2.71x
P/E ratio	34.86x
P/S ratio	2.71x
PE Ratio10 Y	122.82x
PE Ratio3 Y	82.76x
PE Ratio5 Y	122x
PEG ratio	0.67x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	10.71%
EBITDA Margin	13.29%
FCF margin	11.22%
Gross margin	59.98%
Gross Profit	DKK 3.7B
Gross Profit Growth	4.12%
Gross Profit Growth Q	0.64%
Gross Profit Growth3 Y	12.1%
Gross Profit Growth5 Y	8.52%
Net Income	DKK 477M
Net Income Growth	28.92%
Net Income Growth Q	-35.64%
Net Income Growth Years	3%
Net Income Growth5 Y	11.16%
Pretax Margin	10.16%
Profit Margin	7.81%
Profit Per Employee	DKK 91,731
Profitable Years	24
ROA	5.44
Roa5y	4.04
ROCE	9.95
ROE	7.94
Roe5y	5.66
ROIC	8.51
Roic5y	6.53

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	2.95%
Cagr15y	16.16%
Cagr1y	-39.85%
Cagr20y	13.74%
Cagr3y	-15.21%
Cagr5y	-28.17%
Div CAGR10	7.99%
Div CAGR3	12.24%
Div CAGR5	7.17%
EPS Growth	29.57
EPS Growth Q	-35.21
EPS Growth Years	3
EPS Growth5 Y	9.78
FCF Growth	6.86%
FCF Growth Q	36.55%
FCF Growth3 Y	230.35%
FCF Growth5 Y	9.11%
OCF Growth	15.55%
OCF Growth Q	58.39%
OCF Growth10 Y	12.15%
OCF Growth3 Y	92.36%
OCF Growth5 Y	7.39%
Revenue Growth	4.63x
Revenue Growth Q	1.22x
Revenue Growth Quarters	26x
Revenue Growth Years	18x
Revenue Growth3 Y	9.79x
Revenue Growth5 Y	9.76x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	DKK 0.81
Assets	DKK 7.6B
Cash	DKK 691M
Current Assets	DKK 3B
Current Liabilities	DKK 1B
Debt	DKK 551M
Debt EBITDA	DKK 0.63
Debt Equity	DKK 0.09
Debt FCF	DKK 0.8
Equity	DKK 6.1B
Interest Coverage	19.24
Liabilities	DKK 1.5B
Long Term Assets	DKK 4.6B
Long Term Liabilities	DKK 473M
Net Cash	DKK 140M
Net Cash By Market Cap	DKK 0.85
Net Cash Growth	62.79%
Net Debt EBITDA	DKK -0.17
Net Debt Equity	DKK -0.02
Net Debt FCF	DKK -0.2
Tangible Book Value	DKK 2.8B
Tangible Book Value Per Share	DKK 10.61
WACC	10.98

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.92
Inventory Turnover	2
Net Working Capital	DKK 1.4B
Quick ratio	1.62
Working Capital	DKK 2B
Working Capital Turnover	DKK 3.16

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	0.47%
Dividend Growth	7.89%
Dividend Growth Years	2%
Dividend per share	DKK 0.41
Dividend Years	2
Dividend Yield	0.66%
Ex Div Date	2025-12-04
Last Dividend	DKK 0.41
Payout Ratio	23.06%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	33.76%
1Y total return	-39.83%
200-day SMA	86.53
3Y total return	-39.04%
50-day SMA	69.12
50-day SMA vs 200-day SMA	50under200
5Y total return	-80.87%
All Time High	358.7
All Time High Change	-82.6%
All Time High Date	2021-04-27
All Time Low	0.68
All Time Low Change	9,144.44%
All Time Low Date	1998-11-25
ATR	2.41
Beta	1.26
Beta1y	1.13
Beta2y	0.82
Ch YTD	-29.09
High	63.25
High52	111.8
High52 Date	2025-10-07
High52ch	-44.19%
Low	61.8
Low52	60.45
Low52 Date	2026-05-06
Low52ch	3.23%
Ma50ch	-9.72%
Price vs 200-day SMA	-27.88%
RSI	36.9
RSI Monthly	31.57
RSI Weekly	29.88
Sharpe ratio	-1.67x
Sortino ratio	-1.89
Total Return	1.13%
Tr YTD	-29.09
Tr15y	845.84%
Tr1m	-3.26%
Tr1w	-4.66%
Tr3m	-29.01%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	DKK 654M
Operating Income Growth	-17.42
Operating Income Growth Q	-22.77
Operating Income Growth3 Y	63.73
Operating Income Growth5 Y	9
Operating margin	10.71

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	182,857,046%
Net Borrowing	-68,000,000
Shares Insiders	20.23%
Shares Institutions	28.48%
Shares Out	265,099,231
Shares Qo Q	-1.92%
Shares Yo Y	-0.47%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	DKK 651M
Average Volume	1,158,840.1x
Bv Per Share	23.19
CAPEX	DKK -162M
Ch10y	30.27
Ch15y	775.8
Ch1m	-3.26
Ch1w	-4.66
Ch1y	-40.12
Ch20y	1,014.3
Ch3m	-29.01
Ch3y	-39.53
Ch5y	-81.06
Ch6m	-23.67
Change	-0.24%
Change From Open	0.48
Close	62.55
Days Gap	-0.72
Depreciation Amortization	157,000,000
Dollar Volume	65,970,028.8
Earnings Date	2026-05-06
EBIT	DKK 654M
EBITDA	DKK 811M
EPS	DKK 1.79
F Score	6
FCF	DKK 685M
FCF EV Yield	4.18x
FCF Per Share	DKK 2.58
Financing CF	-327,000,000
Fiscal Year End	September
Founded	1,937
Goodwill	1,511,000,000
Graham Number	30.52407
Graham Upside	-51.08
Income Tax	DKK 143M
Investing CF	-472,000,000
Is Primary Listing	1
Last Earnings Date	2026-05-06
Last Report Date	2026-03-31
Last Split Date	2018-01-03
Last Split Type	Forward
Lynch Fair Value	DKK 20.09
Lynch Upside	-67.81
Ma150	83.4
Ma150ch	-25.18%
Ma20	65.75
Ma20ch	-5.1%
Net CF	51,000,000
Next Earnings Date	2026-08-26
Open	62.1
P FCF Ratio	24.15
P OCF Ratio	19.53
Payment Date	2025-12-08
Position In Range	41.38
Ppne	1,206,000,000
Price Date	2026-05-08
Price EBITDA	DKK 20.4
Ptbv Ratio	5.93
Relative Volume	0.91x
Revenue	6,104,000,000x
SBC By Revenue	0.56x
Share Based Comp	34,000,000
Tax By Revenue	2.34x
Tax Rate	23.06%
Tr20y	1,213.08%
Tr6m	-23.31%
Volume	1,057,212
Z Score	12.46

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

CPH/AMBU.B dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+0.7%

$0.41 annual per share

Payout ratio

+23.1%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+7.2%

2 consecutive years of growth

Total shareholder yield

+1.1%

Next ex-dividend date: 2025-12-04

Performance

CPH/AMBU.B stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns CPH/AMBU.B?

Insider, institutional, and short-interest positioning.

Institutional ownership

+28.5%

Share of float held by funds and institutions

Insider ownership

+20.2%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

-0.5%

Negative means the company is buying back shares.

Technical

CPH/AMBU.B momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

36.9

Neutral momentum band

Price vs 200-day MA

-27.9%

50/200-day relationship not available

Beta (5Y)

1.26

More volatile than the market

Sharpe ratio

-1.67

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About CPH/AMBU.B

Hub-level FAQ points readers to the deeper analysis pages.

What is the current cph/AMBU.B stock rating?

cph/AMBU.B is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full cph/AMBU.B analysis?

The full report lives at /stocks/cph/AMBU.B/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for cph/AMBU.B?

The latest report frames cph/AMBU.B around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the cph/AMBU.B page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.